Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes
Andrzej S. Królewski(Joslin Diabetes Center), Per‐Henrik Groop(University of Helsinki), Jan Skupień(Harvard University), Robert C. Stanton, Lesley A. Inker(Tufts Medical Center), Valma Harjutsalo(Research Council of Finland), Lena M. Thorn(University of Helsinki), Adam M. Smiles(Joslin Diabetes Center), Carol Forsblom(University of Helsinki), John H. Eckfeldt(University of Minnesota), James H. Warram(Joslin Diabetes Center)
Cited by 69
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
|New England Journal of Medicine|2012|4.1k
2. Classification and Diagnosis of Diabetes:<i>Standards of Care in Diabetes—2023</i>
|Diabetes Care|2022|2.4k
Physical activity and incidence of non-insulin-dependent diabetes mellitus in women
|The Lancet|1991|1.2k